{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-016685","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2025-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.026014+00:00","generated_at":"2026-05-17T04:56:10.679822+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Insight Molecular grants stock options to four executives, amends CSO employment to indefinite term","bullets":["Stock options: CEO Riggs 400k shares; CFO James and CSO Schütz 235k each; VP Liu 18k; exercise price $3.33.","Options vest over 3 years: 1/3 on first anniversary, then monthly over next 2 years, subject to continued service.","CSO Schütz's employment term amended from fixed 4-year to indefinite until termination; effective Sept 29, 2025.","Amendment removes references to 'Term Expiration' from severance provisions; all other terms unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-016685","json":"https://secwatch.observer/filing/0001493152-25-016685.json","markdown":"https://secwatch.observer/filing/0001493152-25-016685.md","text":"https://secwatch.observer/filing/0001493152-25-016685.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225016685/0001493152-25-016685-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225016685/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:56:10.679822+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}